Literature DB >> 21262503

Statin therapy in the prevention and treatment of atrial fibrillation.

Yi Lin Lee1, Michael J Blaha, Steven R Jones.   

Abstract

Atrial fibrillation (AF) is the most common adult rhythm disorder, and it is associated with a substantial rate of morbidity and economic burden. There is an increasing body of literature in which the authors investigated the pleiotropic effects of statin therapy in relation to AF. In this comprehensive review, we examine the mechanism of AF as well as potential mechanisms supporting statin use in both the prevention and treatment of AF. In clinical studies, statin therapy appears to be useful in the prevention of AF in patients with coronary artery disease and possibly congestive heart failure and in the prevention of perioperative AF in cardiac surgery. Its utility in patients with paroxysmal AF may be limited to the prevention of incident AF, but it does not appear to inhibit the progression of paroxysmal AF to chronic AF. Further large scale, randomized, placebo-controlled studies are needed in perioperative use in noncardiac surgery and in patients undergoing ablation or cardioversion of AF. Copyright Â
© 2011 National Lipid Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21262503     DOI: 10.1016/j.jacl.2010.11.002

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN: 1876-4789            Impact factor:   4.766


  4 in total

1.  Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation.

Authors:  Evan L Thacker; Paul N Jensen; Bruce M Psaty; Barbara McKnight; W T Longstreth; Sascha Dublin; Katherine M Newton; Nicholas L Smith; David S Siscovick; Susan R Heckbert
Journal:  Ann Pharmacother       Date:  2015-01-27       Impact factor: 3.154

2.  Association of clinical predictors with recurrence of atrial fibrillation after catheter ablation.

Authors:  Ang Li; Yue Chen; Wei Wang; Li Su; Zhiyu Ling
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-07-05       Impact factor: 1.468

3.  Upstream therapeutic strategies of Valsartan and Fluvastatin on Hypertensive patients with non-permanent Atrial Fibrillation (VF-HT-AF): study protocol for a randomized controlled trial.

Authors:  Wen-Wei Qi; Tong Liu; Gang Xu; Li-Feng Li; Ying-Zi Liang; Lan Ye; Guang-Ping Li
Journal:  Trials       Date:  2015-08-07       Impact factor: 2.279

4.  Chloride Channels are Involved in the Development of Atrial Fibrillation - A Transcriptomic and proteomic Study.

Authors:  Yi-Yao Jiang; Hai-Tao Hou; Qin Yang; Xiao-Cheng Liu; Guo-Wei He
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.